natgillin/translations-raw huggingface dataset:
a treatment with INCIVO, peginterferon alfa, and ribavirin.
a zdravljenje z zdravilom INCIVO, peginterferonom alfa, in ribavirinom.
A trend toward improved ORR was observed in patients with 17p deletion treated with MabCampath (64% v 20%; p=0.0805).
Trend povečevanja ORR je mogoče opaziti pri bolnikih z izbrisom 17p, zdravljenih z zdravilom MabCampath (64 % proti 20
A trend towards less efficacy with increasing age has been observed in patients receiving ramucirumab plus docetaxel for the treatment of advanced NSCLC with disease progression after platinum-based chemotherapy (see section 5.1).
Pri bolnikih, ki so prejemali ramucirumab in docetaksel za zdravljenje napredovalega NSCLC z napredovanjem bolezni po kemoterapiji na osnovi platine (glejte poglavje 5.1), so opazili trend manjše učinkovitosti z naraščajočo starostjo.
A trend towards worse survival was observed with Vectibix in the wild-type KRAS subset of the bevacizumab and oxaliplatin cohort, and a trend towards worse survival was observed with Vectibix in the bevacizumab and irinotecan cohort regardless of KRAS mutational status.
V podskupini bevacizumab in oksaliplatinske kohorte z divjim tipom KRAS je bil z zdravilom Vectibix opažen trend k slabšemu preživetju, v bevacizumab in irinotekanski kohorti pa je bil opažen trend k slabšemu preživetju ne glede na mutacijsko stanje KRAS.
A tube can be inserted into your back e.g. for anaesthesia or pain relief during or after surgery.
V hrbet, v bližini hrbtenice, vam bodo lahko vstavili cevko (kateter), na primer za anestezijo ali lajšanje bolečine med operacijo ali po njej.
A tube of REGRANEX should be used on a single patient only.
Posamezno tubo zdravila REGRANEX uporabljajte le za zdravljenje enega bolnika.
A tumour was considered to be EGFR- expressing if at least one stained cell could be identified.
Upoštevali so, da tumor izraža EGFR, če je bilo mogoče določiti najmanj eno obarvano celico.
A Turkey 14/98 ......................................................................................................................... ≥ 6 PD50*
A Turkey 14/98 ..........................................................................................................................≥ 6 ZO50
A Turkey 14/98 and Asia 1 Shamir
in Asia 1 Shamir
A two-stage phase Ib trial to investigate the pharmacokinetics, safety and tolerability of MabThera subcutaneous formulation in patients with follicular lymphoma (FL) as part of maintenance treatment.
Pri bolnikih s folikularnimi limfomi so kot del vzdrževalnega zdravljenja izvedli dvostopenjsko preskušanje faze Ib za proučitev farmakokinetike, varnosti in prenašanja podkožne oblike zdravila MabThera.
A type I glass vial of 3 ml containing freeze-dried attenuated live viral components with a butyl elastomer stopper.
3 mililitrska viala iz stekla tipa I, ki vsebuje liofilizirane oslabljene žive virusne sestavine, z zamaškom iz butil elastomera.
A type of anaemia where your red and white blood cells and platelets are reduced.
vrsta anemije, pri kateri je število eritrocitov, levkocitov in trombocitov zmanjšano
a type of antibiotic called an aminoglycoside – such as gentamicin, tobramycin
vrsto antibiotikov, imenovanih aminoglikozidi – na primer gentamicin, tobramicin,
A type of blood cancer (lymphoma)
vrsta krvnega raka (limfom)
A type of blood cancer (lymphoma)
vrsta krvnega raka (limfom),
A type of diarrhoea (colitis).
posebna vrsta driske (kolitis)
A type of glue known as a fibrin sealant, which is made from blood clotting proteins, is used to hold the implant in place on the cartilage.
Vsadek se na hrustanec pritrdi s fibrinskim lepilom, izdelanim iz beljakovin, ki povzročajo strjevanje krvi.
a type of high pressure in the eyes called narrow-angle glaucoma
vrsto zvišanega očesnega tlaka, imenovanega glavkom ozkega zakotja,
A type of rash that affects the hands and feet (hand foot syndrome).
posebna vrsta izpuščaja, ki prizadene dlani in podplate (sindrom dlani in podplatov)
A type of skin cancer (cutaneous squamous cell carcinoma)
vrsta kožnega raka (ploščatocelični karcinom kože),
A type of skin cancer called basal cell carcinoma (BCC) has been reported in MS patients treated with Gilenya.
Pri bolnikih z multiplo sklerozo, ki so prejemali zdravilo Gilenya, so poročali o vrsti kožnega raka, ki ga imenujemo bazalnocelični karcinom.
a Upon recovery to ANC 1.0 x 109/l (1000 cells/mm3) and platelets to 50 x 109/l (50,000 cells/mm3), the doses should be modified to the next lower dose level according to the table above.
a Po izboljšanju ANC na  1,0 x 109/l (1.000 celic/mm3) in trombocitov na  50 x 109/l (50.000 celic/mm3) je treba odmerke spremeniti na naslednjo raven zmanjšanih odmerkov v skladu z zgornjo preglednico.
a urinary disorder (especially linked to enlarge prostrate in men)
motenj uriniranja (pri moških še zlasti v povezavi s povečano prostato),
a urinary disorder (especially linked to enlarged prostrate in men)
motenj uriniranja (pri moških še zlasti v povezavi s povečano prostato),
A used IONSYS should not be reapplied to patients.
Uporabljen sistem IONSYS se ne sme ponovno namestiti.
A used pipette should immediately be disposed of.
Uporabljeno merilno kapalko je treba takoj zavreči.
A vaccine against a specific disease ‘teaches’ the immune system (the body’s natural defences) to defend itself against the disease.
Cepiva delujejo tako, da imunski sistem (naravni obrambni mehanizem telesa) „naučijo‟, kako naj se brani pred boleznijo.
A vaccine is available to protect those at risk from becoming infected with HBV.
Za zaščito oseb, pri katerih obstaja tveganje za okužbo s HBV, je na voljo cepivo.
A validated test should be performed using either tumour DNA derived from a tissue sample or circulating tumour DNA (ctDNA) obtained from a plasma sample.
Opraviti je treba validirano preiskavo tumorske DNK, dobljene iz vzorca tkiva, ali tumorske DNK v obtoku (ctDNA – circulating tumor DNA), dobljene iz vzorca plazme.
A value < 1 favours olaparib.
Vrednost < 1 je v korist olapariba.
a values presented for GIOTRIF vs. chemotherapy, p-value based on logistic regression b p-value for time to deterioration based on stratified log-rank test
a vrednosti za GIOTRIF v primerjavi s kemoterapijo; vrednost p na osnovi logistične regresije b vrednost p za čas do poslabšanja na osnovi stratificiranega testa log-rank
a variation in the number of red blood cells (which carry oxygen), white blood cells (which are important in fighting infection) or platelets (cells which help the blood to clot)
premembe v številu rdečih krvnih celic (celice, ki po krvi prenašajo kisik), belih krvnih celic (celice, ki so pomembne za obrambo pred okužbami) ali trombocitov (celice, ki so potrebne za normalno strjevanje krvi)
A variety of innovations, such as techniques for early detection of Epstein-Barr (EBV) and CMV infections, bone marrow augmentation, the adjunct use of the interleukin-2 antagonist daclizumab, lower initial tacrolimus doses with target trough levels of 10 to 15 nanogram/ml, and most recently allograft irradiation were considered to have contributed to improved results in this indication over time.
Domnevno so k izboljšanju rezultatov skozi čas pri tej indikaciji pripomogle različne inovacije, npr. postopki za zgodnje odkrivanje okužb z virusom Epstein-Barr (EBV) in CMV, prirast kostnega mozga, dodatna uporaba antagonista interlevkina-2 daklizumaba, manjši začetni odmerki takrolimusa s ciljno najnižjo koncentracijo od 10 do 15 nanogram/ml in, v najnovejšem času, obsevanje alotransplantata.
A variety of innovations, such as techniques for early detection of Epstein-Barr (EBV) and CMV infections, bone marrow augmentation, the adjunct use of the interleukin-2 antagonist daclizumab, lower initial tacrolimus doses with target trough levels of 10 to 15 nanogram/ml, and most recently allograft irradiation were considered to have contributed to improved results in this indication over time.
Domnevno so k izboljšanju rezultatov skozi čas pri tej indikaciji pripomogle različne inovacije, npr. postopki za zgodnje odkrivanje okužb z virusom Epstein-Barr (EBV) in CMV, prirast kostnega mozga, dodatna uporaba antagonista interlevkina-2 daklizumaba, manjši začetni odmerki takrolimusa s ciljno najnižjo koncentracijo od 10 do 15 nanogramg/ml in, v najnovejšem času, obsevanje alotransplantata.
A variety of neoplasms, including mammary carcinomas, keratocanthoma of the skin and basal cell adenoma were observed in the 6- cycle rat study while no tumours or pre-neoplastic changes were evident in dog studies.
V študiji na podganah, ki je obsegala šest ciklov, so opazili različne neoplazme, vključno s karcinomom mlečnih žlez, keratoakantomom in adenomom bazalnih celic, medtem ko v študijah na psih niso opazili tumorjev ali predneoplastičnih sprememb.
A variety of neoplasms, including mammary carcinomas, keratocanthoma of the skin and basal cell adenoma were observed in the 6-cycle rat study while no tumours or pre-neoplastic changes were evident in dog studies.
V šest-ciklični študiji pri podganah so opažali vrsto neoplazem vključno s karcinomi dojk, keratokantomom kože in adenomom bazalnih celic, medtem ko pri psih niso opažali tumorjev ali preneoplastičnih sprememb.
A venous access should be established for a 500 mL bag of sodium chloride 9 mg/mL (0.9%) solution for injection or glucose 50 mg/mL (5%) solution for infusion, on a large vein preferably in the upper part of the forearm or using a central venous line.
Na veliki veni, najbolje na zgornjem delu podlakti, ali s centralnim venskim katetrom pripravite venski dostop za 500-mililitrsko vrečo raztopine natrijevega klorida 9 mg/ml (0,9 %) za injiciranje ali raztopine glukoze 50 mg/ml (5 %) za infundiranje.
A vented infusion line should be used for the administration of Privigen.
Za infundiranje zdravila Privigen je treba uporabiti prezračevano infuzijsko cevko.
a Very common = Reported in  1 patient receiving KANUMA
a Zelo pogosti = o njih so poročali pri  1 bolniku, ki je dobival zdravilo KANUMA
A very common side effect (these may affect more than 1 in 10 people) which may show up in blood tests is: an increase in the level of some liver enzymes (transaminases), which may be a sign of inflammation or damage in the liver.
Zelo pogost neželeni učinek (pojavi se lahko pri več kot 1 od 10 bolnikov), ki se lahko pokaže pri preiskavah krvi, je: zvišana vrednosti nekaterih jetrnih encimov (transaminaz); to je lahko znak vnetja jeter.
A very common side effect (these may affect more than 1 in 10 people) which may show up in blood tests is: an increase in the level of some liver enzymes (transaminases), which may be a sign of inflammation or damage in the liver.
Zelo pogost neželeni učinek (pojavi se lahko pri več kot 1 od 10 bolnikov), ki se lahko pokaže pri preiskavah krvi, je: zvišanje vrednosti nekaterih jetrnih encimov (transaminaz); to je lahko znak vnetja jeter.
A very fast heart beat
zelo hiter srčni utrip,
A very frequent side effect of filgrastim use is pain in your muscles or bones (musculoskeletal pain), which can be helped by taking standard pain relief medicines (analgesics).
Zelo pogost neželeni učinek uporabe filgrastima je bolečina v mišicah ali kosteh (mišično-skeletna bolečina), pri kateri pomagajo standardna zdravila za lajšanje bolečin (analgetiki).
A very frequent side effect of filgrastim use is pain in your muscles or bones (musculoskeletal pain), which can be helped by taking standard pain relief medicines (analgesics).
Zelo pogost neželeni učinek uporabe filgrastima so bolečine v mišicah in kosteh (mišično-skeletne bolečine), ki jih je mogoče lajšati s standardnimi protibolečinskimi zdravili (analgetiki).
A very frequent side effect of Grastofil use is pain in your muscles or bones (musculoskeletal pain), which can be helped by taking standard pain relief medicines (analgesics).
Zelo pogosti neželeni učinek zdravila Grastofil so bolečine v mišicah in kosteh (mišično-skeletne bolečine), ki jih je mogoče olajšati z jemanjem običajnih protibolečinskih zdravil (analgetikov).
a very high level of fat in the blood (cholesterol or triglycerides)
zelo visoko koncentracijo maščob v krvi (holesterola ali trigliceridov)
a very high level of fat in the blood (cholesterol or triglycerides);
zelo visoko koncentracijo maščob v krvi (holesterola ali trigliceridov)
A very low risk cannot be totally excluded with Raplixa.
Zelo majhnega tveganja pri uporabi zdravila Raplixa ni mogoče v celoti izključiti.
A very rare effect is skin rash with blisters affecting the lips, eyes, mouth, sometimes with headache, fever and/or diarrhoea.
Zelo redek učinek je kožni izpuščaj z mehurčki na ustnicah, očeh in v ustih, včasih z glavobolom, zvišano telesno temperaturo in/ali drisko.
A very rare side effect (these may affect up to 1 in 10,000 people) is: lactic acidosis (excess lactic acid in the blood).
Zelo redek neželeni učinek (pojavi se lahko pri največ 1 od 10.000 bolnikov) je: laktacidoza (presežek mlečne kisline v krvi).
A very rare side effect that may show up in blood tests is: a failure of the bone marrow to produce new red blood cells (pure red cell aplasia).
Zelo redek neželeni učinek, ki se lahko pokaže v preiskavah krvi, je: nesposobnost kostnega mozga proizvajati nove rdeče krvne celice (čista aplazija rdečih krvnih celic).
A very rare side effect that may show up in blood tests is: a failure of the bone marrow to produce new red or white blood cells (aplastic anaemia)
Zelo redek neželen učinek, ki ga lahko pokažejo preiskave krvi, je: nezmožnost kostnega mozga za tvorbo novih rdečih ali belih krvnih celic (aplastična anemija)
A very rare side effect that may show up in blood tests is: a failure of the bone marrow to produce new red or white blood cells (aplastic anaemia).
Zelo redek neželeni učinek, ki se lahko pokaže v preiskavah krvi, je: nezmožnost kostnega mozga za tvorbo novih rdečih ali belih krvnih celic (aplastična anemija).
a very slow heart rate (bradycardia)
zelo počasen srčni utrip (bradikardijo),
a very slow heart rate (bradycardia),
zelo počasen srčni utrip (bradikardijo),
A very slow heartbeat
zelo počasno bitje srca
A very small number of people who have used Protopic ointment have had malignancies (for example, skin or lymphoma).
Zelo maloštevilni bolniki, ki so uporabljali zdravilo Protopic, so imeli malignome (npr. na koži ali limfom).
A vial contains 9.75 mg (1.3 ml) aripiprazole.
Viala vsebuje 9,75 mg (1,3 ml) aripiprazola.
A vial of Herceptin reconstituted with water for injections (not supplied) is stable for 48 hours at 2ºC – 8 ºC after reconstitution and must not be frozen.
Po rekonstituciji vsebine viale zdravila Herceptin z vodo za injekcije (ni dodana) je pripravljena raztopina stabilna 48 ur pri temperaturi 2 °C–8 °C. Pripravljene raztopine ne smemo zamrzniti.
A vial of ZYPREXA can provide you with 10 mg of olanzapine.
Iz viale ZYPREXE lahko dobimo 10 mg olanzapina.
A vial provides 9.75 mg in 1.3 ml.
Viala vsebuje 9,75 mg v 1,3 ml.
A viral infection causing cold sores (herpes).
virusna okužba, ki povzroči izpuščaje (herpes)
A volume overage of 4 % ensures that the labelled dose of 150 mg can be withdrawn from each vial.
4 % presežek volumna omogoča, da na nalepki naveden odmerek 150 mg res odvzamemo iz viale.
a warning card that informs about the correct pressures and distances for the spray application for open and laparoscopic procedures a tag, to be placed on the device air hose, which provides instructions for use.
opozorilno kartico z navedbo ustreznega tlaka in razdaljo od tkiva za uporabo pršilnika pri odprtih in laparoskopskih posegih; oznako za namestitev na zračno cev naprave, kjer so navedena navodila za uporabo.
A warning message for HCPs treating the patient at any time, including emergency conditions, that the patient is using BLINCYTO
Opozorilo za zdravstvene delavce, ki kadar koli zdravijo bolnika, vključno v izrednih razmerah, da bolnik uporablja zdravilo BLINCYTO.
A warning message for HCPs treating the patient at any time, including in conditions of emergency, that the patient is using IMLYGIC
Opozorilo za zdravstvene delavce, ki kadar koli zdravijo bolnika, vključno z urgentnimi primeri, da bolnik uporablja zdravilo IMLYGIC.
A warning to minimise the risk of over-chelation
opozorilo za zmanjšanje tveganja za prekomerno kelacijo,
A washout period corresponding to 5 half-lives of the SSRI used previously should be considered prior to initiating treatment with Xadago.
Pred začetkom zdravljenja z zdravilom Xadago je treba razmisliti o obdobju izpiranja, ki ustreza petim razpolovnim časom predhodno uporabljenega selektivnega zaviralca ponovnega privzema serotonina.
A washout period corresponding to 5 half-lives of the SSRI used previously should be considered prior to initiating treatment with Xadago.
Pred začetkom zdravljenja z zdravilom Xadago je treba razmisliti o obdobju izpiranja, ki ustreza petim razpolovnim časom predhodno uporabljenega SSRI.
a water tablet called furosemide a medicine for gout called probenecid
tablete za odvajanje vode, imenovane furosemid, zdravilo proti protinu, imenovano probenecid.
A WCBP is defined in the Erivedge Pregnancy Prevention Programme as:
Program preprečevanja nosečnosti med uporabo zdravila Erivedge opredeljuje žensko v rodni dobi kot:
a weak heart (decompensated cardiac failure) which is not under close medical observation,
rčno popuščanje (dekompenzirana srčna bolezen), ki ni pod skrbnim zdravniškim nadzorom,
a weak heart (heart failure)
šibko srce (srčno popuščanje),
A weakness of the heart muscle or heart failure
šibkost srčne mišice ali srčno popuščanje
a Week 24 window is between day 127 and 210 (inclusive). b Snapshot analysis.
a Okno v 24. tednu je med 127. in 210. dnevom (vključno z njima). b Analiza posnetka stanja.
a Week 48 window is between day 309 and 378 (inclusive) b Week 144 window is between day 967 and 1,050 (inclusive) c Includes subjects who had ≥ 50 copies/ml in the week 48 or 144 windows; subjects who discontinued early due to lack or loss of efficacy; subjects who discontinued for reasons other than an adverse event, death or lack or loss of efficacy, and at the time of discontinuation had a viral value of ≥ 50 copies/ml. d Includes patients who discontinued due to adverse event (AE) or death at any time point from day 1 through
a Okno 48. tedna je med 309. in 378. dnevom (vključno z njima) b Okno 144. tedna je med 967. in 1.050. dnevom (vključno z njima) c Vključuje osebe, ki so imele v oknu 48. ali 144. tedna ≥ 50 kopij/ml; osebe, ki so predčasno prekinile sodelovanje zaradi pomanjkanja ali izgube učinkovitosti; osebe, ki so sodelovanje prekinile zaradi razlogov,
a Whenever possible, the BO segment selected for treatment should include normal tissue margins of a few millimetres at the proximal and distal ends.
a Kadar je mogoče, mora segment BP, izbran za zdravljenje, vključevati običajne robove tkiv nekaj milimetrov na proksimalnih in distalnih koncih.
A white to slightly yellowish ointment.
Belo do rahlo rumenkasto mazilo.
A white, biconvex, round tablet, with the inscription “OL 10” on one side.
Bela, bikonveksna okrogla tableta z napisom »OL 10« na eni strani.
A white, biconvex, round tablet, with the inscription “OL 2.5” on one side.
Bela, bikonveksna okrogla tableta z napisom »OL 2,5« na eni strani.
A white, biconvex, round tablet, with the inscription “OL 5” on one side.
Bela, bikonveksna okrogla tableta z napisom »OL 5« na eni strani.
A white, biconvex, round tablet, with the inscription “OL 7.5” on one side.
Bela, bikonveksna okrogla tableta z napisom »OL 7,5« na eni strani.
A whole body autoradiography study in rats has shown that ruxolitinib does not penetrate the blood-brain barrier.
Rezultati študije z avtoradiografijo celega telesa na podganah so pokazali, da ruksolitinib ne prehaja krvno- možganske pregrade.
A wide variety of autoimmune and immune-mediated disorders have been reported with alpha interferons including thyroid disorders, systemic lupus erythematosus, rheumatoid arthritis (new or aggravated), idiopathic and thrombotic thrombocytopenic purpura, vasculitis, neuropathies including mononeuropathies and Vogt-Koyanagi-Harada syndrome (see also section 4.4).
Pri uporabi interferonov alfa so poročali o širokem razponu avtoimunih bolezni in drugih motenj imunskega izvora, vključno z motnjami žleze ščitnice, sistemskim eritematoznim lupusom, revmatoidnim artritisom (novonastalim ali poslabšanim), idiopatsko in trombotično trombocitopenično purpuro, vaskulitisom, nevropatijami, vključno z mononevropatijami in sindromom Vogt-Koyanagi- Harada (glejte tudi poglavje 4.4).
a with ritonavir oral solution: 80 mg/ml
a peroralna raztopina ritonavirja: 80 mg/ml
A worsening of asthma
poslabšanje astme;
A worsening of chorea (an existing neurological disorder characterised by involuntary spasmodic movements of the body)
poslabšanje horeje (obstoječe nevrološke bolezni, za katero so značilni nenadzorovani spastični gibi telesa);
A wound that does not heal.
rana, ki se ne celi.
a yellow plunger in the medicine window
zdravilo morate videti rumeni bat (glejte
A yellow solution.
Etanol 150 mg Rumena raztopina.
A yellow solution.
Prozorna rumena raztopina.
A yellow, round, biconvex tablet with 10 mm of diameter.
Rumena, okrogla, bikonveksna tableta, premera 10 mm.
A yellow, round, biconvex tablet, with 11 mm of diameter.
Rumena, okrogla, bikonveksna tableta, premera 11 mm.
A yellow, round, biconvex tablet, with 12 mm of diameter.
Rumena, okrogla, bikonveksna tableta, premera 12 mm.
A yellow, round, biconvex tablet, with 8 mm of diameter.
Rumena, okrogla, bikonveksna tableta, premera 8 mm.
A yellowish-red body and yellowish-red cap, approximately 14.3 mm in length, marked in black ink with
Rumenkastordeče telo kapsule in rumenkastordeč pokrovček kapsule; kapsula je dolga približno
a – Logistic regression model adjusted for randomisation stratification variables
a – Logistični regresijski model, prilagojen za randomizacijske stratificirane spremenljivke
A ‘booster’ injection should be given every year to maintain the vaccine’s effect.
Za vzdrževanje učinka cepiva je treba nato vsako leto psu injicirati obnovitveni odmerek.
a ‘Case’ = HIV seroconverter; ‘Cohort’ = 100 randomly selected subjects from each of the tenofovir disoproxil 245 mg (as fumarate) and Truvada groups.
a »Študijska skupina« = serokonverter HIV; »podskupina« = 100 naključno izbranih oseb iz vsake od skupin, ki so prejemale dizoproksiltenofovirat 245 mg (v obliki fumarata) in ki prejemajo zdravilo Truvada.
A ‘penile modeling procedure’ is then performed by the doctor after a further 1 to 3 days to gently stretch and bend the plaque in the opposite direction to the abnormal curvature.
Zdravnik nato po enem do treh dneh izvede postopek oblikovanja penisa, s katerim nežno raztegne in ukrivi plak v smeri, ki je nasprotna smeri nenormalne ukrivljenosti.
A ‘response’ was defined as a combination of a 10% improvement in exercise capacity (measured by looking at how far the patient could walk in six minutes) and an improvement of the patient’s condition (the severity of the disease going down by at least one class), without a worsening of pulmonary hypertension or death.
Odziv je bil opredeljen kot kombinacija 10-odstotnega izboljšanja fizične zmogljivosti (ki je bila ocenjena z merjenjem dolžine, ki jo je bolnik lahko prehodil v šestih minutah) in izboljšanja bolnikovega stanja (resnost obolenja se je ublažila za vsaj en funkcijski razred) brez poslabšanja pljučne hipertenzije ali nastopa smrti.
A ‘response’ was defined as a fall in the levels of HIV in the blood (viral load) by 90% or more that was maintained until the end of the 48 weeks.
Odziv je bil opredeljen kot padec ravni virusa HIV v krvi (virusna obremenitev) za 90 % ali več, ki se je ohranil do konca 48 tednov.
A “dose preparation guide” (specially designed underside of the tray) is provided to assist you with aligning the vial and the solvent syringe.
“Vodilo za pripravo odmerkov” (posebno oblikovana spodnja stran podstavka) vam bo pomagalo, da boste pravilno naravnali vialo in injekcijsko brizgo z vehiklom.